{
  "@context": "aku-v2",
  "@type": "clinical-syndrome",
  "@id": "vasc:vasculitis:egpa",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:35:00.000Z",
    "updated": "2026-01-07T03:35:00.000Z",
    "contributors": [
      "knowledge-graph-agent"
    ],
    "confidence": 0.9,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vasculitis",
    "type": "anca-vasculitis",
    "difficulty": "advanced",
    "importance": "moderate"
  },
  "content": {
    "title": "Eosinophilic Granulomatosis with Polyangiitis (EGPA)",
    "description": "Formerly Churg-Strauss syndrome - eosinophil-rich necrotizing vasculitis",
    "key_concepts": [
      {
        "concept": "Features",
        "details": "Asthma, eosinophilia, granulomatous inflammation"
      },
      {
        "concept": "Phases",
        "details": "Prodromal (allergic), eosinophilic infiltration, vasculitic phase"
      },
      {
        "concept": "ANCA",
        "details": "MPO-ANCA positive in 40-60%; ANCA-negative EGPA has more cardiac involvement"
      },
      {
        "concept": "Cardiac",
        "details": "Cardiomyopathy and myocarditis major causes of mortality"
      }
    ],
    "clinical_significance": "Distinct phenotypes based on ANCA status with different organ involvement",
    "statement": "Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Vasculitis that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Eosinophilic Granulomatosis with Polyangiitis (EGPA) helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Eosinophilic Granulomatosis with Polyangiitis (EGPA) include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Eosinophilic Granulomatosis with Polyangiitis (EGPA)."
    }
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Eosinophilic Granulomatosis with Polyangiitis (EGPA). Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}